MAVERIC Trial of the ARTO System Encompasses Four Continents and 15 centers of Excellence
The MAVERIC (MitrAl ValvE RepaIr Clinical) trial program is a prospective, single arm group of studies evaluating the safety and performance of the ARTO System in patients with congestive heart failure associated with mitral regurgitation.
"Ten years ago, I had a heart attack and was treated with a stent. When my condition worsened, I was offered this operation, which made me feel much better. These days, I exercise with my hunting dog: I cycle and he follows me. He is very strong, so have to keep up. And I do!"
– E.L., MAVERIC Trial patient, Latvia